Informations sur le produit
- Quinoxaline, 2-Chloro-6,7-Difluoro-
2-Chloro-6,7-difluoroquinoxaline is a quinoxaline derivative that inhibits the growth of cancer cells in vitro. It has shown anticancer activity against a variety of cancers, including breast cancer and melanoma. 2-Chloro-6,7-difluoroquinoxaline inhibits the production of acetyl coenzyme A (acetyl CoA), which is an important metabolic intermediate in the citric acid cycle. This drug also inhibits the growth of cancer cells by inhibiting cell proliferation and inducing apoptosis.